Abbott Laboratories
NYS : ABT
Pharmaceuticals
Abbott Park IL
Pharmaceuticals
Abbott Park IL
| Current Rank | 56 |
| Prior Rank | 33 |
| Executive 1 | Mr. Miles D. White, Chairman; Chief Executive Officer |
| Executive 2 | Mr. Hubert L. Allen, Executive Vice President; Secretary; General Couns |
| 2013 Revenue (US$ Millions) | $21,848 |
| 2012 Revenue (US$ Millions) | $39,874 |
| Revenue Growth (%) | -45.21% |
| Net Income (US$ Millions) | $2,576 |
| Common Shares Outstanding (Millions) | $1,548 |
| Earnings Per Share (US$) | $1.62 |
| Price To Earnings Ratio | 65.5 |
| Total Equity (US$ Millions) | $25,171 |
| Profit Margin (%) | 11.79% |
| Return On Equity (%) | 9.64% |
| Long Term Debt (US$ Millions) | $3,388 |
| Debt To Equity Ratio (%) | 0.13% |
| Market Capitalization (US$ Millions) | $59,339 |
| Total Assets (US$ Millions) | $42,953 |
| Return on Assets (%) | 3.83 |
| Current Assets (US$ Millions) | $19,247 |
| Inventories (US$ Millions) | $2,693 |
| Current Liabilities (US$ Millions) | $9,507 |
| Cost of Goods Sold (US$ Millions) | $10,040 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.1 |
| Exchange | NYS |